Jun
2026
Shanghai New International Expo Center
Visit us
stand E7F70b, Pharma Ingredients
Zone

Zhejiang Better Pharmaceuticals Co., Ltd.

Exhibitor at CPHI & PMEC China 2026
About Us

Better Pharma manufactures and sells APIs, pharmaceutical preparations, and pharmaceutical intermediates. The first phase production capability can reach 250 tons of APIs; 500,000,000 tablets as well as capsules; 25,000,000 units of lyophilized powder for injection; 20,000,000 units of Cephalosporins powder for injection. 

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
Wholesale/Retail
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E7F70b, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • adefovir dipivoxil

    Product adefovir dipivoxil

    Zhejiang better pharmaceuticals offers a wide range of products which includes adefovir dipivoxil. It belongs to Apis,Intermediates category.. Contact us for more information.
  • Anti-infection drugs

    Product Anti-infection drugs

    Zhejiang better pharmaceuticals offers a wide range of products which includes anti-infection drugs. Contact us for more information.
  • Anti-ulcer drugs

    Product Anti-ulcer drugs

    Zhejiang better pharmaceuticals offers a wide range of products which includes anti-ulcer drugs. Contact us for more information.
  • Antivirals for hepatitis b

    Product Antivirals for hepatitis b

    Zhejiang better pharmaceuticals offers a wide range of products which includes antivirals for hepatitis b . Contact us for more information.
  • atorvastatin calcium

    Product atorvastatin calcium

    Zhejiang better pharmaceuticals offers a wide range of products which includes atorvastatin calcium. It belongs to Apis,Intermediates category.. Contact us for more information.